Resolve Therapeutics (United States)
- Research works
- 41 ▲ 37% vs 2013–17
- Citations
- 868 21.1 per fractional work
- Top-10% rate
- 9.3% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Resolve Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.5×
- Immunology and Microbiology 4.1×
- Veterinary 2.8×
- Medicine 2.4×
- Environmental Science 1.2×
- Business, Management and Accounting 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Arts and Humanities 0.6×
- Agricultural and Biological Sciences 0.5×
- Health Professions 0.4×
- Psychology 0.4×
- Mathematics 0.4×
- Social Sciences 0.2×
- Computer Science 0.1×
- Engineering 0.1×
- Economics, Econometrics and Finance 0.0×
Which keywords describe research at Resolve Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Genomic Analysis, Chromatin Remodeling, SWI/SNF Complexes, Tumor Microenvironment, Cancer Therapy and BET Bromodomains.
- IL-6
- Prognostic Factors
- Fibroblast Activation Protein
- Tumorigenesis
- Pim Oncogenes
- CAR T Cells
- Inflammation
- Cell Proliferation
- Immunotherapy
- Palbociclib
- Lymphoma
- Breast Cancer
- Cancer Therapy
- Tumor Microenvironment
- Genomic Analysis
- Transcriptional Regulation
- Cancer
- Chromatin Remodeling
- SWI/SNF Complexes
- BET Bromodomains
- PROTACs
- CDK4/6 Inhibitors
- Metastatic Breast Cancer
- Cancer Immunotherapy
- PET Imaging
- Cancer Progression
- Metastasis
- Chimeric Antigen Receptor
- Rituximab
- Angiogenesis
- Immunosuppression
- Apoptosis
- STAT3
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 33 words, with their numbers
- Cancer5▲ 14×5 topics
- Transcriptional Regulation3▲ 67×2 topics
- Chromatin Remodeling2▲ 1018×1 topic
- Genomic Analysis2▲ 41×2 topics
- SWI/SNF Complexes2▲ 1018×1 topic
- Tumor Microenvironment2▲ 20×4 topics
- BET Bromodomains2▲ 256×1 topic
- Cancer Therapy2▲ 13×5 topics
- PROTACs2▲ 256×1 topic
- Breast Cancer2▲ 29×2 topics
- CDK4/6 Inhibitors2▲ 266×1 topic
- Lymphoma2▲ 43×3 topics
- Metastatic Breast Cancer2▲ 121×2 topics
- Palbociclib2▲ 266×1 topic
- Cancer Immunotherapy2▲ 42×2 topics
- Immunotherapy2▲ 8.8×4 topics
- PET Imaging2▲ 37×3 topics
- Cell Proliferation2▲ 72×2 topics
- Cancer Progression1▲ 30×2 topics
- Inflammation1▲ 2.6×5 topics
- Metastasis1▲ 16×2 topics
- CAR T Cells1▲ 70×1 topic
- Chimeric Antigen Receptor1▲ 70×1 topic
- Pim Oncogenes1▲ 272×1 topic
- Rituximab1▲ 35×2 topics
- Tumorigenesis1▲ 132×1 topic
- Angiogenesis1▲ 15×2 topics
- Fibroblast Activation Protein1▲ 106×1 topic
- Immunosuppression1▲ 52×1 topic
- Prognostic Factors1▲ 11×6 topics
- Apoptosis1▲ 14×2 topics
- IL-61▲ 181×1 topic
- STAT31▲ 181×1 topic
Which research topics does Resolve Therapeutics (United States) publish most on?
By volume in 2022–2025: Chromatin Remodeling and Cancer, Protein Degradation and Inhibitors, Advanced Breast Cancer Therapies and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chromatin Remodeling and Cancer Molecular Biology 2 works
- 2 Protein Degradation and Inhibitors Molecular Biology 2 works
- 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
- 4 CAR-T cell therapy research Oncology 1 works
- 5 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
- 6 Peptidase Inhibition and Analysis Oncology 1 works
- 7 Cytokine Signaling Pathways and Interactions Oncology 1 works
- 8 Cancer-related gene regulation Molecular Biology 1 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Resolve Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 37% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in St. Petersburg
- University of South Florida St. Petersburg
- Eckerd College
- Sterling Research Group (United States)
- Cognitive Research (United States)
- Johns Hopkins All Children's Hospital
- Meridien Research
- St. Anthony’s Hospital
- Jabil (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.